Anaplastic Large Cell Lymphoma, ALK-Negative

Anaplastic Large Cell Lymphoma, ALK-Negative — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Baylor College of Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07729397	Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)(ANCILE-30)	not yet recruiting	Phase 1	21	The Methodist Hospital Research InstituteOTHER	1	Jul 27, 2026	clinicaltrials
NCT06176690	Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas(CABAL2)	recruiting	Phase 1	90	Baylor College of MedicineOTHER	1